caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1922150234

Injib KimMD

PRACTICESARAH FARAG, MDSee all providers at this practice →
Internal MedicineLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
414
Beneficiaries
—
Total drug cost
$40K
Distinct drugs
19
Brand share
20.3%
Top prescribed drugs
Amlodipine Besylate59 claims
Cefpodoxime Proxetil42 claims
Dabigatran Etexilate Mesylate31 claims
Apixaban26 claims
Prednisone25 claims
REFERRAL NETWORK

Where Injib Kim's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
KAISER FOUNDATION HOSPITALS148189
City Of Los Angeles
Ambulance Service Provider · Los Angeles, CA
1433
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
71
Unique beneficiaries
—
Total services
125
Distinct HCPCS
4
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — below median (cohort median 531).